1. Aga AM, Mekonnen Y, Hurisa B, Tesfaye T, Lemma H, Kebede G, Niguse D, Gwold G, Urga K. In vivo and in vitro cross neutralization studies of local rabies virus isolates with ERA based cell culture anti-rabies vaccine produced in Ethiopia. J Vaccines Vaccin. 2014;5:256.
2. Chavez JH, Yokosawa L, Oliveira TFM, Simoes CMO, Zanetti CR. No association between viral cytopathic effect in McCoy cells and MTT colorimetric assay for the in vitro anti-rabies evaluation. Virus Rev Res. 2013;1:10–8.
3. Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, Schnell MJ, Dietzschold B. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sci USA. 2004;101:16328–32.
4. Goswami A, Plun-Favreau J, Nicoloyannis N, Sampath G, Siddiqui MN, Zinsou JA. The real cost of rabies postexposure treatments. Vaccine. 2005;23:2970–6.
5. Guo C, Wang C, Luo S, Zhu S, Li H, Liu Y, Zhou L, Zhang P, Zhang X, Ding Y, Huang W, Wu K, Zhang Y, Rong W, Tian H. The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development. Virol J. 2014;11:85.